Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Gluckman

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Arzneimittel-Forschung|July 1, 1971
Pharmacology of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam; Wy 4036)M I Gluckman
Diseases of the Nervous System|May 1, 1975
Summary of the animal pharmacology of oxazepamM I Gluckman
The Journal of Clinical Psychiatry|October 1, 1978
Pharmacology of lorazepamM I Gluckman, L Stein
Advances in Biochemical Psychopharmacology|January 1, 1973
Assaying narcotic-antagonist drugs for analgesic activity in rhesus monkeysJ L Malis, M I Gluckman
Arzneimittel-Forschung|January 1, 1983
On the mechanism of the pharmacologic activity of meclofenamate sodiumJ R McLean, M I Gluckman
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1971
Mechanism of antilipolytic effects of cardiac glycosidesD H Yu, S Triester, M I Gluckman
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1976
A comparison of gamma-butyrolactone and pimozide on serum gonadotrophins and ovulation in the ratC W Beattie, M I Gluckman, A Corbin
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1972
Mechanism of the inhibitory effects of cardiac glycosides on lipolysisD H Yu, S Triester, M I Gluckman
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1975
Animal pharmacology of Wy-16,225, a new analgesic agentJ L Malis, M E Rosenthale, M I Gluckman
Pharmacology, Biochemistry, and Behavior|May 1, 1976
Apomorphine self-injection is not affected by alpha-methylparatyrosine treatment: support for dopaminergic rewardB L Baxter, M I Gluckman, R A Scerni
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Arzneimittel-Forschung|July 1, 1971
Pharmacology of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam; Wy 4036)M I Gluckman
Diseases of the Nervous System|May 1, 1975
Summary of the animal pharmacology of oxazepamM I Gluckman
The Journal of Clinical Psychiatry|October 1, 1978
Pharmacology of lorazepamM I Gluckman, L Stein
Advances in Biochemical Psychopharmacology|January 1, 1973
Assaying narcotic-antagonist drugs for analgesic activity in rhesus monkeysJ L Malis, M I Gluckman
Arzneimittel-Forschung|January 1, 1983
On the mechanism of the pharmacologic activity of meclofenamate sodiumJ R McLean, M I Gluckman
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1971
Mechanism of antilipolytic effects of cardiac glycosidesD H Yu, S Triester, M I Gluckman
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1976
A comparison of gamma-butyrolactone and pimozide on serum gonadotrophins and ovulation in the ratC W Beattie, M I Gluckman, A Corbin
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1972
Mechanism of the inhibitory effects of cardiac glycosides on lipolysisD H Yu, S Triester, M I Gluckman
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1975
Animal pharmacology of Wy-16,225, a new analgesic agentJ L Malis, M E Rosenthale, M I Gluckman
Pharmacology, Biochemistry, and Behavior|May 1, 1976
Apomorphine self-injection is not affected by alpha-methylparatyrosine treatment: support for dopaminergic rewardB L Baxter, M I Gluckman, R A Scerni
Pageof 3